Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.
Diabetes Obes Metab. 2020 Nov;22(11):2133-2140. doi: 10.1111/dom.14133. Epub 2020 Jul 22.
Diabetes Obes Metab. 2020.
PMID: 32627316
Free PMC article.